SCHEDULE 13G

Maze Therapeutics Inc

Common Stock, $0.001 par value per share · CUSIP: 578784100

Event date: 2025-01-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Deep Track Capital, LP

  Shares: 3,023,484.00 · Class: 6.91%

• Deep Track Biotechnology Master Fund, Ltd.

  Shares: 3,023,484.00 · Class: 6.91%

• David Kroin

  Shares: 3,023,484.00 · Class: 6.91%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.